What's new in blood cancer clinical trials?
Stay informed with simple, easy-to-understand updates about blood cancer clinical trials and research.
Many people don’t need a trial now, but want to understand what may be available in the future.
We’ll share updates that are relevant to you
Signing up for What’s new in clinical trials is a simple way to receive a quarterly email with updates on clinical trials and research related to your type of blood cancer.
Funding information
Autolus, BeiGene, Bristol Myers Squibb, Eli Lilly, Kyowa Kirin, Novartis, Pfizer and Takeda have provided funding for our Clinical Trials Support Service, but have had no involvement in its development. Read about how we work with the pharmaceutical industry.
1. Who this email update is for
It’s for anyone with the blood cancers listed below who don’t need a trial right now but might in the future. It’s suitable for those who experience periods of monitoring, remission or long-term treatment. Family members, friends and carers are also welcome to sign up
If you need to explore trials now
- If you need to start treatment, are not responding to treatment, or have relapsed, this email update will not meet your needs.
- For personalised support to help you find a trial right now, please get in touch with our Clinical Trial Support Service by completing our online webform. This service is open to anyone, regardless of their type of blood cancer.
Contact our Clinical Trials Support Service
Get personalised support to understand which clinical trials are available - whether you're a patient, carer or healthcare professional.
When you sign up, you’ll select your specific blood cancer type from a list. We use this to subscribe you to the most relevant newsletter category.
1) Chronic Leukaemias (CMML and Rare Leukaemias)
Includes:
- Chronic myeloid leukaemia (CML)
- Chronic myelomonocytic leukaemia (CMML)
- Hairy cell leukaemia/ Hairy cell leukaemia (variant)
- T‑cell prolymphocytic leukaemia (T-PLL)
- Large granular lymphocytic leukaemia (LGLL)
2) Plasma cell neoplasms (Myeloma & Plasma Cell Neoplasms); Conditions related to myeloma and abnormal plasma cells
Includes:
- Multiple Myeloma
- Non‑secretory myeloma
- MGUS (monoclonal gammopathy of undetermined significance)
- Smouldering myeloma
3) Myeloproliferative neoplasms (MPN) & Myelodysplastic syndromes (MDS)
Includes:
- Essential thrombocythaemia (ET)
- Polycythaemia vera (PV)
- Myelofibrosis (MF)
- Myelodysplastic Syndromes (MDS)
- MDS/MPN or MDS/MPN overlap syndromes
4) Low grade B‑cell lymphoma (B‑cell Lymphoma & Waldenström’s research); This group includes some conditions also called leukaemia
Includes:
- Follicular lymphoma (FL)
- Mantle cell lymphoma (MCL)
- Chronic lymphocytic leukaemia (CLL) / small lymphocytic lymphoma (SLL)
- Lymphoplasmacytic lymphoma / Waldenström’s macroglobulinaemia (WM)
- Marginal zone lymphoma (MZL)
2. What you'll receive
Once you sign up, you’ll receive an email every three months.
Depending on what’s new at the time, this may include;
- Easy‑to‑read summaries of blood cancer clinical trials that are recruiting or opening soon
- Updates from the wider category your blood cancer type sits within
- News about new treatments available on the NHS
- Updates from Blood Cancer UK‑funded research
- Helpful resources and webinars to support understanding of trials and research
- A quick link to share feedback, as this is a new offering, your input helps us improve it
Not every email will include all of the above; we’ll share whatever updates are available in that three‑month period.
Important to know
This is not a trial matching service. We do not take your personal medical history, stage or treatment into account. You may receive information about trials that aren’t applicable for your exact situation.
For personalised support with finding a blood cancer clinical trial right now, please get in touch with our Clinical Trial Support Service by completing our online webform. This service is open to anyone, regardless of their type of blood cancer.
Why isn’t my blood cancer included?
The email update focuses on blood cancers where people are often monitored over time or live with their condition long‑term, and where a general update is most helpful. This doesn’t mean research isn’t happening for your blood cancer, or that clinical trials aren’t important. For personalised support, you can contact our Clinical Trials Support Service, which is available to anyone affected by blood cancer.
Thank you to our blood cancer community
When creating “What’s new in clinical trials”, we worked with people affected by blood cancer to meet their needs. People told us they wanted:
- A simple way to see what may be coming in the future
- Information they can trust
- To feel more prepared and reassured
- Support having better conversations with their clinical team
- Less time spent searching online
A feeling of hope from knowing that research is continuing across blood cancer
What is a clinical trial?
Learn more about the science behind clinical trials. How are they planned and run, and by who? Why are they so important?
Contact our support services team
However you're affected by blood cancer, we're here to support you. Get in touch with us if you have a specific question about blood cancer, or just want to talk through how you're feeling.